Evidence map›Paper›PMID 39907618›Full record

ArticleInternational journal of surgery (London, England)2025

Predicting futile outcomes following deceased donor liver transplantation in non-HCC patients with MELD-Na score above 30: a retrospective international multicenter cohort study.

Hye-Sung Jo, Young-In Yoon, Ki-Hun Kim, Parissa Tabrizian, Rebecca Marino, Pedro Marin-Castro, Wellington Andraus, Jongman Kim, Gyu-Seong Choi, Deok-Gie Kim and 6 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of surgery (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Hye-Sung JoDivision of HBP Surgery and Liver Transplantation, Department of Surgery, Korea University College of Medicine, Seoul, Republic of Korea.
Young-In YoonDepartment of Surgery, College of Medicine University of Ulsan, Asan Medical Center, Seoul, Republic of Korea.
Ki-Hun KimDepartment of Surgery, College of Medicine University of Ulsan, Asan Medical Center, Seoul, Republic of Korea.
Parissa TabrizianRecanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY, USA.
Rebecca MarinoRecanati/Miller Transplantation Institute, Mount Sinai Medical Center, New York, NY, USA.
Pedro Marin-CastroLiver and Abdominal Organs Transplantation Division, Department of Gastroenterology, Hospital das Clínicas da Faculdade de Medicina de São Paulo (HC-FMUSP), São Paulo, Brazil.
Wellington AndrausLiver and Abdominal Organs Transplantation Division, Department of Gastroenterology, Hospital das Clínicas da Faculdade de Medicina de São Paulo (HC-FMUSP), São Paulo, Brazil.
Jongman KimDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Gyu-Seong ChoiDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Deok-Gie KimDepartment of Surgery, The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea.
Dong Jin JooDepartment of Surgery, The Research Institute for Transplantation, Yonsei University College of Medicine, Seoul, Republic of Korea.
Carlos Florez-ZorrillaDepartment of HPB and Liver Transplant, Centro Medico Nacional 20 de Noviembre, Mexico.
Deniz BalciDepartment of General Surgery and Organ Transplantation, Bahcesehir University School of Medicine, Istanbul, Turkey.
Henrik PetrowskyDepartment of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Centre, University Hospital Zurich, Zurich, Switzerland.
Karim J HalazunNYU Langone Transplant Institute, NYU Langone Health, New York, NY, USA.
Dong-Sik KimDivision of HBP Surgery and Liver Transplantation, Department of Surgery, Korea University College of Medicine, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn the current "sickest first" allocation policy for limited deceased liver grafts, identifying patients "too sick to transplant" before transplantation is crucial to optimize outcomes. This study aimed to predict futile outcomes following deceased donor liver transplantation (DDLT) in patients with model for end-stage liver disease-sodium (MELD-Na) scores ≥30.

methodsThis international multicenter study was conducted as part of the International Society of Liver Surgeons. We collected data from patients with a MELD-Na score of ≥30 who underwent DDLT. A total of 994 patients were enrolled between 2010 and 2021, including 654 from the Republic of Korea, 224 from the USA, and 116 from other regions. Futility was defined as death within 3 months or during the hospital stay following a DDLT. After exclusion, 160 (16.6%) patients were classified into a futile group and 803 (83.4%) into a non-futile group.

resultsThe MELD-Na scores collected at three time points (listing, matching, and transplantation) were comparable between the groups ( P = 0.442, P = 0.180, and P = 0.554, respectively). Regarding concomitant organ failure factors, the futile group showed a higher incidence of organ dysfunction across all measured parameters, including the use of mechanical ventilators, continuous renal replacement therapy (CRRT), pneumonia, bacteremia, and vasopressor use (all P < 0.01). Independent risk factors for futile outcome were recipient age (≥65 years), body mass index (<18.5 kg/m 2 ), mechanical ventilator use, CRRT (≥1 week), and prolonged intensive care unit stay before transplantation (≥2 weeks). The futility rate was 53.3% in patients with ≥3 risk factors ( P < 0.001). We developed a nomogram to predict futility after DDLT based on multivariate regression analysis, which showed a better predictive power than previous models.

conclusionThe risk factors and new nomogram, which adequately reflect concomitant organ failure before liver transplantation, could effectively predict the risk of futile outcomes after DDLT and contribute to decision-making regarding transplantation eligibility in clinical practice.

Indexed as

End Stage Liver DiseaseLiver TransplantationMedical FutilityAdultAgedFemaleHumansMaleMiddle AgedRepublic of KoreaRetrospective StudiesSeverity of Illness IndexTissue DonorsTreatment Outcomedeceased donor liver transplantationfutilityMELD-Na scorenomogramstreatment outcome

Identifiers

PMID39907618
PMCPMC12165517

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.